TUCSON, AZ / ACCESS Newswire / April 29, 2025 / Retatrutide, also known as LY3437943, is an innovative triple receptor agonist targeting glucose-dependent insulinotropic polypeptide (GIP), ...

New Delhi: Torrent Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug ...

Visakhapatnam: A group of researchers at Andhra University have recently obtained a patent for a portable biosensor designed ...

Fibersol®, a digestion-resistant soluble dietary fiber backed by over 30 years of extensive clinical research, may support ...

Many people experience a serious return of appetite, cravings and weight after coming off Ozempic, and having read far too ...

By inhibiting DPP4, vildagliptin causes an increase in glucagon like peptide-1 (GLP-1), an intestinal hormone that aids in glucose homeostasis and insulin secretion. The manufacturer of ...

Stimulating a receptor in adipocytes enhanced energy expenditure and caused sustained weight loss in mice, offering targets ...

AACR's achievement awards and lectureships recognize innovation in basic, translational, clinical, and epidemiological cancer research.

GLP-1 is a hormone naturally produced by the body that plays a key role in appetite regulation, blood sugar control, and ...

The latest pharmacological treatment approved by the FDA for type 2 diabetes combines glucagon-like peptide-1 (GLP-1 ... 17003 Bleskestad KB, Nordheim E, Lindahl JP, et al. Insulin secretion and ...